Hahn Erin E, Haupt Eric C, Chawla Neetu, Osuji Thearis A, Shen Ernest, Smitherman Andrew B, Casperson Mallory, Kirchhoff Anne C, Zebrack Bradley J, Laurent Cecile A, Keegan Theresa H M, Abrahão Renata, Ruddy Kathryn J, Chubak Jessica, Nichols Hazel B, Wernli Karen J
Kaiser Permanente Southern California Department of Research and Evaluation, Pasadena, CA.
Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA.
JCO Oncol Pract. 2025 Jun 20:OP2400886. doi: 10.1200/OP-24-00886.
Survivors of adolescent and young adult (AYA)-onset cancers require comprehensive cancer surveillance care. Guidelines recommend 1-4 clinician visits annually for 5 years depending on stage and disease. The goal of this study was to identify factors associated with patterns of post-treatment primary and oncology care in a large cohort of survivors of AYA-onset cancers diagnosed within an integrated health care system.
Patients diagnosed with cancer between 2006 and 2020 age 15-39 years were included. Surveillance visits were identified from electronic medical records 2-5 years after diagnosis. Multivariable logistic regression was used to assess associations with zero oncology specialty visits.
Of 7,925 survivors, 46% were Hispanic, 6% non-Hispanic Black, 11% non-Hispanic Asian, 35% non-Hispanic White, and 65% female. One-quarter had no oncology specialty visits in the first surveillance year rising to 38% in year 5; 31% had 3+ visits in the first year, declining to 13% in year 5. Over the surveillance period, 17% did not have any oncology specialty visits and 6% had no primary care or oncology visits. Those who were male (odds ratio [OR], 1.21 [95% CI, 1.02 to 1.45]), 20-24 years at diagnosis (OR, 1.58, 95% CI, 1.27 to 1.9; 35 to 39), or non-Hispanic Black (OR, 1.38, 95% CI, 1.05 to 1.82; non-Hispanic White) or had high-deductible commercial or Medicaid insurance (OR, 1.35, 95% CI, 1.15 to 1.59; OR, 1.42, 95% CI, 1.11 to 1.82, respectively; no or low deductible commercial) were more likely to be in the 0-visit group for oncology specialty care.
Although the majority of this cohort received either primary or oncology specialty care, our study identifies those who may need tailored outreach for follow-up care. Continued research into development and testing of interventions to improve uptake of appropriate health care for survivors of AYA-onset cancers is critical.
青少年及青年期(AYA)起病癌症的幸存者需要全面的癌症监测护理。指南建议根据癌症分期和疾病情况,在5年内每年进行1 - 4次临床医生问诊。本研究的目的是在一个综合医疗系统中确诊的一大群AYA起病癌症幸存者中,确定与治疗后初级和肿瘤护理模式相关的因素。
纳入2006年至2020年间确诊癌症、年龄在15 - 39岁的患者。从诊断后2 - 5年的电子病历中识别监测问诊情况。采用多变量逻辑回归评估与零次肿瘤专科问诊的关联。
在7925名幸存者中,46%为西班牙裔,6%为非西班牙裔黑人,11%为非西班牙裔亚洲人,35%为非西班牙裔白人,65%为女性。四分之一的患者在首次监测年没有进行肿瘤专科问诊,这一比例在第5年升至38%;31%的患者在第一年进行了3次及以上问诊,在第5年降至13%。在整个监测期内,17%的患者没有进行任何肿瘤专科问诊,6%的患者没有进行初级护理或肿瘤问诊。男性(优势比[OR],1.21[95%置信区间,1.02至1.45])、诊断时年龄为20 - 24岁(OR,1.58,95%置信区间,1.27至1.9;35至39岁)、非西班牙裔黑人(OR,1.38,95%置信区间,1.05至1.82;非西班牙裔白人)或拥有高免赔额商业保险或医疗补助保险(OR,1.35,95%置信区间,1.15至1.59;OR,1.42,95%置信区间,1.11至1.82,分别对应;无或低免赔额商业保险)的患者更有可能属于肿瘤专科护理零问诊组。
尽管该队列中的大多数患者接受了初级或肿瘤专科护理,但我们的研究确定了那些可能需要针对性随访护理推广的患者。持续开展研究以开发和测试干预措施,以提高AYA起病癌症幸存者对适当医疗护理的接受度至关重要。